Company / Revenue
60 DEGREES PHARMACEUTICALS, INC. Revenue History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$607.6K
FY2025
5-year range
$223.2K / $607.6K
FY2023-FY2025
Trend
+139.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $223,208 to $607,574 over the past 2 years.
Based on SEC 10-K filings.
$607,574 in FY2025.
Improved from $223,208 to $607,574 over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue increased 139.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score -4.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $607.6K | +139.6% |
| FY2024 | $253.6K | +13.6% |
| FY2023 | $223.2K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026